UPDATED RESULTS OF THE FIL "MIRO" STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA. (17th June 2021)

• Record Type: Journal Article
• Authors: Pulsoni, A.; Tosti, M. E.; Ferrero, S.; Luminari, S.; Dondi, A.; Liberati, A. M.; Cenfra, N.; Renzi, D.; Zanni, M.; Boccomini, C.; Ferreri, A. J.; Rattotti, S.; Zilioli, V. R.; Bernuzzi, P.; Bolis, S.; Musuraca, G.; Nassi, L.; Perrone, T.; Stelitano, C.; Anastasia, A.; Corradini, P.; Partesotti, G.; Re, F.; Cencini, E.; Mannarella, C.; Mannina, D.; Molinari, A. L.; Tani, M.; Annechini, G.; Assanto, G. M.; Grapulin, L.; Guarini, A.; Cavalli, M.; De Novi, L. A.; Ciabatti, E.; Mantoan, B.; Della Starza, I.; Arcaini, L.; Ricardi, U.; Gattei, V.; Galimberti, S.; Ladetto, M.; Foà, R.; Del Giudice, I.;
• Is Part Of: Hematological oncology. Volume 39(2021)Supplement 2
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-17
• Subjects: Molecular Targeted Therapies Immunotherapy; Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.31_2880
• Languages: English
• ISSNs: 0278-0232